Logo image of SDHC

SMITH DOUGLAS HOMES CORP (SDHC) Stock Fundamental Analysis

NYSE:SDHC - New York Stock Exchange, Inc. - US83207R1077 - Common Stock - Currency: USD

22.535  -1.09 (-4.59%)

Fundamental Rating

4

Taking everything into account, SDHC scores 4 out of 10 in our fundamental rating. SDHC was compared to 66 industry peers in the Household Durables industry. SDHC is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. SDHC has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year SDHC was profitable.
In the past year SDHC had a positive cash flow from operations.
SDHC Yearly Net Income VS EBIT VS OCF VS FCFSDHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 50M 100M

1.2 Ratios

SDHC's Return On Assets of 9.05% is fine compared to the rest of the industry. SDHC outperforms 67.19% of its industry peers.
With an excellent Return On Equity value of 60.85%, SDHC belongs to the best of the industry, outperforming 98.44% of the companies in the same industry.
The Return On Invested Capital of SDHC (23.35%) is better than 96.88% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SDHC is significantly above the industry average of 12.03%.
The 3 year average ROIC (37.98%) for SDHC is well above the current ROIC(23.35%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 9.05%
ROE 60.85%
ROIC 23.35%
ROA(3y)42.96%
ROA(5y)N/A
ROE(3y)69.93%
ROE(5y)N/A
ROIC(3y)37.98%
ROIC(5y)N/A
SDHC Yearly ROA, ROE, ROICSDHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 20 40 60 80

1.3 Margins

SDHC has a Profit Margin of 4.60%. This is comparable to the rest of the industry: SDHC outperforms 46.88% of its industry peers.
The Operating Margin of SDHC (13.17%) is better than 75.00% of its industry peers.
SDHC has a Gross Margin of 26.53%. This is comparable to the rest of the industry: SDHC outperforms 53.13% of its industry peers.
Industry RankSector Rank
OM 13.17%
PM (TTM) 4.6%
GM 26.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SDHC Yearly Profit, Operating, Gross MarginsSDHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 5 10 15 20 25

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SDHC is creating value.
SDHC has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, SDHC has a worse debt to assets ratio.
SDHC Yearly Shares OutstandingSDHC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M 40M 50M
SDHC Yearly Total Debt VS Total AssetsSDHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 100M 200M 300M

2.2 Solvency

SDHC has an Altman-Z score of 5.36. This indicates that SDHC is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 5.36, SDHC belongs to the best of the industry, outperforming 81.25% of the companies in the same industry.
SDHC has a debt to FCF ratio of 0.11. This is a very positive value and a sign of high solvency as it would only need 0.11 years to pay back of all of its debts.
SDHC has a better Debt to FCF ratio (0.11) than 85.94% of its industry peers.
SDHC has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.05, SDHC is in the better half of the industry, outperforming 76.56% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.11
Altman-Z 5.36
ROIC/WACC2.54
WACC9.18%
SDHC Yearly LT Debt VS Equity VS FCFSDHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 50M 100M 150M 200M

2.3 Liquidity

SDHC has a Current Ratio of 5.39. This indicates that SDHC is financially healthy and has no problem in meeting its short term obligations.
SDHC has a better Current ratio (5.39) than 75.00% of its industry peers.
A Quick Ratio of 0.42 indicates that SDHC may have some problems paying its short term obligations.
SDHC's Quick ratio of 0.42 is on the low side compared to the rest of the industry. SDHC is outperformed by 89.06% of its industry peers.
Industry RankSector Rank
Current Ratio 5.39
Quick Ratio 0.42
SDHC Yearly Current Assets VS Current LiabilitesSDHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 50M 100M 150M 200M

2

3. Growth

3.1 Past

SDHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.74%.
SDHC shows a small growth in Revenue. In the last year, the Revenue has grown by 1.23%.
EPS 1Y (TTM)-23.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-97.65%
Revenue 1Y (TTM)1.23%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%40.58%

3.2 Future

The Earnings Per Share is expected to grow by 5.33% on average over the next years.
SDHC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.74% yearly.
EPS Next Y0.9%
EPS Next 2Y1.51%
EPS Next 3Y5.3%
EPS Next 5Y5.33%
Revenue Next Year25.56%
Revenue Next 2Y17.51%
Revenue Next 3Y16.08%
Revenue Next 5Y14.74%

3.3 Evolution

SDHC Yearly Revenue VS EstimatesSDHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
SDHC Yearly EPS VS EstimatesSDHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 5.35, the valuation of SDHC can be described as very cheap.
Based on the Price/Earnings ratio, SDHC is valued cheaper than 95.31% of the companies in the same industry.
SDHC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.62.
With a Price/Forward Earnings ratio of 12.56, SDHC is valued correctly.
The rest of the industry has a similar Price/Forward Earnings ratio as SDHC.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, SDHC is valued a bit cheaper.
Industry RankSector Rank
PE 5.35
Fwd PE 12.56
SDHC Price Earnings VS Forward Price EarningsSDHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SDHC is on the same level as its industry peers.
SDHC's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 36.64
EV/EBITDA 9.88
SDHC Per share dataSDHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)5.92
PEG (5Y)N/A
EPS Next 2Y1.51%
EPS Next 3Y5.3%

0

5. Dividend

5.1 Amount

SDHC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SMITH DOUGLAS HOMES CORP

NYSE:SDHC (2/24/2025, 11:04:53 AM)

22.535

-1.09 (-4.59%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)03-12 2025-03-12/amc
Inst Owners109.1%
Inst Owner ChangeN/A
Ins Owners3.84%
Ins Owner Change2.57%
Market Cap1.16B
Analysts49.09
Price Target25.7 (14.04%)
Short Float %5.69%
Short Ratio4.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.35%
Min EPS beat(2)0.69%
Max EPS beat(2)20.01%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.55%
Min Revenue beat(2)3.56%
Max Revenue beat(2)5.54%
Revenue beat(4)3
Avg Revenue beat(4)1.97%
Min Revenue beat(4)-1.52%
Max Revenue beat(4)5.54%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.29%
PT rev (3m)-11.58%
EPS NQ rev (1m)-1.81%
EPS NQ rev (3m)-1.38%
EPS NY rev (1m)-0.39%
EPS NY rev (3m)4.4%
Revenue NQ rev (1m)-0.57%
Revenue NQ rev (3m)-0.45%
Revenue NY rev (1m)0.3%
Revenue NY rev (3m)2.09%
Valuation
Industry RankSector Rank
PE 5.35
Fwd PE 12.56
P/S 1.28
P/FCF 36.64
P/OCF 33.06
P/B 16.89
P/tB 27.06
EV/EBITDA 9.88
EPS(TTM)4.21
EY18.68%
EPS(NY)1.79
Fwd EY7.96%
FCF(TTM)0.62
FCFY2.73%
OCF(TTM)0.68
OCFY3.02%
SpS17.65
BVpS1.33
TBVpS0.83
PEG (NY)5.92
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.05%
ROE 60.85%
ROCE 29.56%
ROIC 23.35%
ROICexc 24.81%
ROICexgc 28.61%
OM 13.17%
PM (TTM) 4.6%
GM 26.53%
FCFM 3.48%
ROA(3y)42.96%
ROA(5y)N/A
ROE(3y)69.93%
ROE(5y)N/A
ROIC(3y)37.98%
ROIC(5y)N/A
ROICexc(3y)43.51%
ROICexc(5y)N/A
ROICexgc(3y)46.77%
ROICexgc(5y)N/A
ROCE(3y)48.07%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.97
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.11
Debt/EBITDA 0.03
Cap/Depr 242.03%
Cap/Sales 0.38%
Interest Coverage 250
Cash Conversion 28.98%
Profit Quality 75.73%
Current Ratio 5.39
Quick Ratio 0.42
Altman-Z 5.36
F-Score3
WACC9.18%
ROIC/WACC2.54
Cap/Depr(3y)103.57%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.15%
Cap/Sales(5y)N/A
Profit Quality(3y)67.46%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-97.65%
EPS Next Y0.9%
EPS Next 2Y1.51%
EPS Next 3Y5.3%
EPS Next 5Y5.33%
Revenue 1Y (TTM)1.23%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%40.58%
Revenue Next Year25.56%
Revenue Next 2Y17.51%
Revenue Next 3Y16.08%
Revenue Next 5Y14.74%
EBIT growth 1Y-11.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3.3%
EBIT Next 3Y7.71%
EBIT Next 5Y5.83%
FCF growth 1Y-42.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-42.27%
OCF growth 3YN/A
OCF growth 5YN/A